Consumer News: Amazon is mailing out previously returned items – here’s how to spot one

Prices for everything from smartphones to cars may go up

By Mark Huffman of ConsumerAffairs

• Surging demand for artificial intelligence chips is straining global semiconductor supply chains

• Chipmakers are prioritizing high-margin AI processors over components used in everyday electronics

• Analysts warn consumers could face higher prices for phones, cars, and home appliances as a result

The explosive growth of artificial intelligence is reshaping the global semiconductor marketand consumers may soon feel the impact in their wallets.

As technology companies race to build more powerful AI systems, demand for advanced chips used in data centers, cloud computing, and large language models has surged to unprecedented levels. While this boom has been a financial windfall for chipmakers, industry analysts say it could also drive up prices for consumer devices that rely on the same manufacturing ecosystem.

Modern electronicsfrom smartphones and laptops to cars, washing machines, and even thermostatsdepend on a steady supply of computer chips. But semiconductor fabrication capacity is finite, and manufacturers are increasingly allocating resources to produce high-end AI chips, which command far higher prices and profit margins than traditional processors.

"I keep telling everybody that if you want a device, you buy it now," Avril Wu, a senior research vice president at TrendForce, told NPR. "I myself bought an iPhone 17 already."

Higher costs for device makers

That pressure could translate into higher costs for device makers, which may be passed on to consumers.

At the heart of the issue is competition for fabrication capacity at advanced chip foundries. Producing cutting-edge AI chips requires the most sophisticated manufacturing processes, often at the same facilities that make processors for premium smartphones, PCs, and automotive systems.

When foundry capacity tightens, smaller or lower-margin orders can be delayed or become more expensive. Device manufacturers may face higher prices for components, longer lead times, or both.

Automakers are particularly vulnerable. Modern vehicles can contain thousands of chips controlling everything from engine performance to infotainment systems and driver-assistance features. The auto industry is still recovering from chip shortages that disrupted production during the pandemic, and renewed supply constraints could slow manufacturing or raise vehicle prices again.

Consumer electronics companies face similar risks. Even modest increases in chip costs can have an outsized impact in highly competitive markets where profit margins are thin.

Why AI chips are different

AI chips are not just another product categorythey are fundamentally changing the economics of the semiconductor industry.

Unlike general-purpose processors, AI chips are often custom-designed and optimized for specific workloads, such as training or running AI models. These chips require advanced materials, complex packaging, and leading-edge manufacturing techniques.

As a result, they consume a disproportionate share of engineering talent, factory time, and capital investment.

Some chipmakers are expanding capacity, but building new fabrication plants can take years and cost tens of billions of dollars. In the short term, supply constraints are difficult to avoid, and that could lead to higher prices for consumer electronics.

Most forecasts see rates leveling off during much of the year

By Mark Huffman of ConsumerAffairs

• Freddie Macs latest Primary Mortgage Market Survey (PMMS) shows the average 30-year fixed-rate mortgage (FRM) fell to 6.15% this week.

• After starting the year close to 7%, the average 30-year fixed-rate mortgage moved to its lowest level in 2025 this week, said Freddie Mac Chief Economist Sam Khater.

• The 15-year FRM averaged 5.44%, down from 5.50% a week earlier, and well below the year-ago level of 6.13%.

Mortgage rates ended 2025 on a gentler note, offering homebuyers a sliver of relief after another year of elevated borrowing costs. Freddie Mac reported that the average 30-year fixed-rate mortgage fell to 6.15% this week, down slightly from 6.18% the prior week. One year earlier, the same benchmark averaged 6.91%.

The decline matters because the 30-year fixed rate is the backbone of the U.S. home-loan market, shaping affordability for millions of buyers. Freddie Macs Sam Khater framed the move as a positive signal heading into the new year, noting rates began 2025 near 7% before sliding to their lowest level of the year in the final week.

The shorter-term 15-year fixed rate also moved lower, averaging 5.44% (down from 5.50% a week earlier), and sitting well below the 6.13% level seen a year ago. That drop is especially relevant for homeowners who are closer to refinancing territorythough most borrowers with older, ultra-low pandemic-era mortgages still have little incentive to swap into todays rates.

Affordability is still an issue

Mortgage rates dont move in lockstep with the Federal Reserves short-term policy rate. Instead, theyre heavily influenced by longer-term bond yieldsespecially the 10-year Treasuryplus expectations for inflation, economic growth, and investor demand for mortgage-backed securities.

Even with the latest decline, affordability remains strained in many markets. A recent Zillow analysis found that to restore typical affordability (mortgage payments below 30% of median household income), the national average 30-year rate would need to fall more than about 0.4 percentage points from levels around the low-6% rangeand in some high-cost metros, even dramatic rate drops wouldnt be enough on their own.

In other words, lower rates help, but prices, inventory, insurance and tax costs, and household incomes also have to cooperate.

The 2026 mortgage rate forecast: modest improvement, not a plunge

Looking into 2026, major forecasters largely agree on one theme: rates may ease, but the back to 5% quickly dream is not the base case. The disagreement is more about how much relief arrivesand when.

There are two big forecasts to watch:

• Fannie Mae: below 6% by late 2026, but not far below. Fannie Maes Economic and Strategic Research (ESR) group has projected mortgage rates ending 2026 around 5.9%, implying the 30-year could dip under the 6% threshold toward the back half of the year.
• Mortgage Bankers Association: A stuck in the 6s outlook.
  

MBAs December 2025 Mortgage Finance Forecast is more cautious. Its table shows the 30-year fixed rate averaging 6.3%6.4% through 2026, with Q4 2026 at 6.4%.

Put together, the range of mainstream expectations suggests 2026 may look less like a rate breakdown and more like a slow driftwith periodic volatility if inflation or the broader economy surprises.

Medicare negotiated prices may fall, but prices of 350 other drugs may rise

By Mark Huffman of ConsumerAffairs

• Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP analysis.

• The savings stem from the first round of drug price negotiations under the Inflation Reduction Act, affecting 10 widely used brand-name drugs.

• In contrast, another report shows drugmakers planning price hikes on at least 350 other medicines in 2026, potentially offsetting some broader cost relief.

As millions of Americans start 2026, a new AARP report highlights dramatic savings on prescription drugs for Medicare beneficiaries, while a separate industry forecast warns that price increases on hundreds of other medications may temper overall relief.

According to AARPs latest analysis, out-of-pocket costs for the first 10 drugs subject to Medicares price negotiation program are expected to fall by an average of more than 50% beginning January 1. These negotiated prices made possible by the Inflation Reduction Act of 2022 could save Medicare Part D enrollees an estimated $1.5 billion in total out-of-pocket spending next year.

The negotiated drugs include treatments for conditions such as heart disease, diabetes, rheumatoid arthritis, and autoimmune disorders and cover medications used by nearly 9 million seniors across the country. Under the new pricing, most beneficiaries taking these drugs will see significantly smaller copayments and coinsurance costs, which advocates say will improve access to essential therapies.

More affordable lifesaving medicine

Medicare prescription drug negotiation is on track to deliver billions in savings for Americas seniors starting in January, making lifesaving medication more affordable, said AARP Executive Vice President Nancy LeaMond in a statement accompanying the report.

However, the broader prescription drug market tells a more complex story. In a report released late this week, industry data show that drugmakers are planning price increases on at least 350 branded medicines in 2026, including widely used vaccines and cancer treatments. The median planned price hike is roughly 4%, similar to increases in 2025.

Companies such as Pfizer, Sanofi, and GSK are among those proposing higher prices on a range of products, from COVID-19 vaccines to oncology therapies. Critics argue that these increases could erode some of the gains from Medicares negotiated savings for non-Medicare patients and for drugs not yet subject to negotiation.

Systemic price pressures

Health policy experts contend that while Medicares negotiation program marks a significant shift toward affordability for seniors, systemic drug pricing pressures remain. Partial cuts and negotiated deals do little to address the underlying issue of high list prices, one analyst noted, pointing to the planned price increases.

Looking ahead, the Medicare program plans to negotiate prices on additional medications in subsequent years, with 15 more drugs slated for negotiation in 2027 and further expansions in the years after.

Former head of FTC's Bureau of Consumer Protection named

It's been called New York City's FTC. The NYC Department of Consumer and Worker Protection is a powerful agency whose authority stretches into every corner of the city's life or, to be more precise, can do so if the mayor names an aggressive consumer champion to run the department.

And newly-inaugurated Mayor Zohran Mamdani has done just that, appointing Sam Levine to head the department. Levinewas formerly the director of the Federal Trade Commission's Bureau of Consumer Protection, where he led the FTC's groundbreaking work on junk fees, privacy protection, fraudulent auto dealer conduct, and other critical consumer and worker protections.

"We fight for people who often can't fight back on their own. And when companies are ripping people off or putting kids and teens at risk, there's nothing prudent about sitting on the sidelines," Levine said in farewell remarks to the FTC in January 2025. "There's nothing responsible about hoping someone else, somewhere else, steps in to do what must be done. For an agency like ours, inaction is a choice that has real consequences in people's lives."

Endorsements fromconsumer leaders